# A Safety and Efficacy Study With YM543 in Type 2 Diabetes Mellitus Subjects

> **NCT00454233** · PHASE2 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 97 (actual)

## Conditions studied

- Diabetes Mellitus Type 2

## Interventions

- **DRUG:** YM543
- **DRUG:** Metformin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00454233
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 97 (ACTUAL)
- **Last updated:** 2008-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00454233

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00454233, "A Safety and Efficacy Study With YM543 in Type 2 Diabetes Mellitus Subjects". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00454233. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*